Search results
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 6 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 6 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
AstraZeneca’s Lung, Breast Cancer Drugs Markedly Slow Disease
Bloomberg· 4 days agoAstraZeneca Plc’s lung and breast cancer drugs significantly slowed the spread of disease in two...
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 6 days agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 3 days agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
Theralase(R) Successfully Destroys Lung Cancer
Digital Journal· 12 hours agocancers, bacteria and viruses, is pleased to announce that it's lead compound, RuvidarTM, combined with transferrin to form the compound Rutherrin®, has been proven effective ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 6 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Study reveals role of neutrophil lipid transfer in lung cancer transition
Medical Xpress· 1 day agoPhenotypic plasticity is a cancer hallmark, and lung adeno-to-squamous transition (AST) triggered by...
Researchers say AI blood test provides a reliable way to identify lung cancer
Medical Xpress· 6 hours agoIn a prospective study published June 3 in Cancer Discovery, the team demonstrated that artificial intelligence technology could identify people more likely to have